Impact of hospital admissions for pneumonia in a tertiary Spanish hospital;Impacto sanitario de los ingresos por neumonía en un hospital de tercer nivel

Medicina Clinica

Volumn 116, Issue 18, 2001, Pages 694-695

  Bayas, José María ^a   Vilella, Anna ^a   San Martín, María ^b   González, Antonio ^b   Conesa, Artur ^c   Asenjo, Miguel Ángel ^a  

^a HOSPITAL CLÍNIC   (Spain)

^b Sanofi Pasteur MSD   (Spain)

^c Hospital Clínic ^*

Author keywords

Hospitalization; Pneumonia; Spain

Indexed keywords

AGED; ARTICLE; FEMALE; HOSPITALIZATION; HUMAN; MALE; MIDDLE AGED; PNEUMONIA; RETROSPECTIVE STUDY; SPAIN; STATISTICS;

AGED; FEMALE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PNEUMONIA; RETROSPECTIVE STUDIES; SPAIN;

EID: 0039560768     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0025-7753(01)71955-0     Document Type: Article

References (10)

1. Plans Rubió P, Garrido Morales P, Salleras Sanmartí L. Coste-efectividad de la vacunación neumocócica en Cataluña. Rev Esp Salud Pública 1995; 69: 409-417.
2. Vaqué J, Roselló J, Trilla A, Monge V, Garcia-Caballero J, Arribas JL et al. Nosocomial infections in Spain: results of five nationwide serial prevalence surveys (EPINE Project, 1990 to 1994). Nosocomial Infections Prevalence Study in Spain. Infect Control Hosp Epidemiol 1996; 17: 293-297.
3. a ed.). Filadelfia: WB Saunders, 1999; 553-607.
4. Ament A, Baltussen R, Duru G, Rigaud-Bully C, De Graeve D, Örtqvist A et al. Cost-effectiveness of pneumococcal vaccination of older people: a study in 5 western European countries. Clin Infect Dis 2000; 31: 444-450.
5. Álvarez-Sánchez B, Álvarez-Lerma F, Jordȧ R, Serra J, López-Cambra MJ, Sandar MD, y Grupo de estudio de neumonia comunitaria grave en España. Factores pronósticos y etiología de los pacientes con neumonia comunitaria grave ingresados en UCI. Estudio multicéntrico español. Med Clin (Barc) 1998; 111: 650-654.
6. Pérez Martín A, Garcia Garcia FJ, Martín Correa E, Romero Rizos L, Rodríguez Barquero MJ, Echevarría Santamaria I et al. Factores de riesgo de ingreso hospitalario en mayores de 64 años. Gac Sanit 2000; 14: 363-370.
7. Fedson DS, Houck P, Bratzler D. Hospital-based influenza and pneumococcal vaccination: Sutton's law applied to prevention. Infect Control Hosp Epidemiol 2000; 21: 692-699.
8. Butler JC, Breiman RF, Campbell JF, Lipman HB, Broome CV, Facklam RR. Pneumococcal polysaccharide vaccine efficacy: an evaluation of current recommendations. JAMA 1993; 270: 1826-1831.
9. Nichol KL, Baken L, Wuorema J, Nelson A. The health and economic benefits associated with pneumococcal vaccination of elderly persons with chronic lung disease. Arch Intern Med 1999; 159: 2437-2442.
10. Nichol KL. The additive benefits of influenza and pneumococcal vaccinations during influenza seasons among elderly persons with chronic lung disease. Vaccine 1999; 17: S91-S93.